News

Emery Pharma and Telo Genomics Announce Collaboration

Telo Genomics Corp. (TSXV: TELO; OTCQB: TDSGF) (the “Company” or “Telo”) a biotech company developing the industry’s leading telomere technology platform with diagnostic and prognostic applications in oncology is pleased to announce that…

Read More

Emery Pharma Exhibiting at the 2024 AAPS National Biotechnology Conference in San Francisco, California

Alameda, CA – Emery Pharma is thrilled to announce its participation as an exhibitor at the 2024 AAPS National Biotechnology Conference, scheduled to be held on May 13-16, 2024, at the…

Read More

Emery Pharma Exhibiting at the 2024 Society of Toxicology Annual Meeting in Salt Lake City, Utah

Alameda, CA – Emery Pharma is excited to announce its participation as an exhibitor at the Society of Toxicology (SOT) Annual Meeting, scheduled to be held on March 10-13, 2024, at…

Read More

Emery Pharma Attending 2024 J.P. Morgan 42nd Annual Healthcare Conference

ALAMEDA, CA. – Emery Pharma has announced that CEO, Ron Najafi, Ph.D., and the Business Development team will be available during the JP Morgan Annual Healthcare Conference, held on January…

Read More

Emery Pharma Exhibiting at the 2023 AAPS Annual Meeting in Orlando, Florida

Alameda, CA – Emery Pharma is excited to announce its participation as an exhibitor at the American Association of Pharmaceutical Scientists (AAPS) Conference, scheduled to be held on October 22-25,…

Read More

Emery Pharma to Participate in 2023 ACS National Meeting & Expo, San Francisco

San Francisco, CA: Emery Pharma is excited to announce its participation in the prestigious American Chemical Society’s (ACS) National Meeting & Expo in San Francisco, California, taking place from August…

Read More

Poster Presentation at the American Society for Mass Spectrometry

Alameda, CA – Emery Pharma, a contract research organization located in Alameda, CA, presented an innovative poster at the 71st ASMS 2023 (American Society for Mass Spectrometry) Annual Conference in…

Read More

PR-GenNext® Technologies and Emery Pharma Announce Partnership on Full-Solution Biopharmaceutical Protein Footprinting Services

Alameda, CA -May 17, 2021 – GenNext Technologies, Inc., a growth-stage company that provides structural biology instrumentation, software, and services, announced today that it is collaborating with Emery Pharma, a…

Read More

Attending 2023 J.P. Morgan 41st Annual Healthcare Conference

ALAMEDA, CA. – Emery Pharma has announced that Ron Najafi, Ph.D., CEO of Emery Pharma, will be available during the JP Morgan Annual Healthcare Conference, held on January 9 – 11th,…

Read More

Nitrosamine Impurity Found in Januvia®, a Popular Diabetes Medication

A Nitrosamine impurity known as Nitroso-STG-19 (NTTP), has been identified in Januvia®, a popular diabetes drug developed by Merck & Co. Januvia® (sitagliptin), is an oral medication used to treat…

Read More